Featured Research

from universities, journals, and other organizations

More Studies Needed To Determine Genetic Controls Of Il-4 Receptors In Allergies and Asthma, According To National Jewish Medical And Research Center Physician

Date:
December 10, 1997
Source:
National Jewish Medical And Research Center
Summary:
A National Jewish researcher who earlier reported genetic variations of interleukin-4 in people predisposed to asthma and allergies writes in tomorrow’s edition of the New England Journal of Medicine that new research increasing understanding of the role of IL-4 receptors in genetic predisposition to these diseases deserves continued exploration.

DENVER-A National Jewish Medical and Research Center researcher who earlier reported genetic variations of interleukin-4 in people predisposed to asthma and allergies writes in today’s edition of the New England Journal of Medicine that new research increasing understanding of the role of IL-4 receptors in genetic predisposition to these diseases deserves continued exploration.

"Research on genetic variations of IL-4 and IL-4 receptors will have value as markers for susceptibility and as models that may lead to innovative treatments for allergic disease and asthma," said Lanny Rosenwasser, M.D., head, Division of Allergy and Clinical Immunolgy at National Jewish.

The new research expands scientists’ understanding of IL-4 receptors. IL-4, a type of protein, or cytokine, released by cells when they come in contact with an allergen, causes the body’s immune system to release substances that cause inflammation in diseases such as asthma. IL-4 is also instrumental in causing the immune sytem to produce the allergic antibody IgE. When activated by an allergen entering the body, IL-4 binds to IL-4 receptors causing a series of immune responses by cells. These responses can cause inflammation of the airways.

In clinical trials at National Jewish, researchers are using a soluble form of IL-4 receptors to treat people with asthma who have a particularly high number of the IL-4 receptors. Researchers hope to "turn off" IL-4’s immune response to allergens.

For more information about National Jewish, call (800) 222-LUNG or visit http://www.nationaljewish.org/pa.


Story Source:

The above story is based on materials provided by National Jewish Medical And Research Center. Note: Materials may be edited for content and length.


Cite This Page:

National Jewish Medical And Research Center. "More Studies Needed To Determine Genetic Controls Of Il-4 Receptors In Allergies and Asthma, According To National Jewish Medical And Research Center Physician." ScienceDaily. ScienceDaily, 10 December 1997. <www.sciencedaily.com/releases/1997/12/971210111137.htm>.
National Jewish Medical And Research Center. (1997, December 10). More Studies Needed To Determine Genetic Controls Of Il-4 Receptors In Allergies and Asthma, According To National Jewish Medical And Research Center Physician. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/1997/12/971210111137.htm
National Jewish Medical And Research Center. "More Studies Needed To Determine Genetic Controls Of Il-4 Receptors In Allergies and Asthma, According To National Jewish Medical And Research Center Physician." ScienceDaily. www.sciencedaily.com/releases/1997/12/971210111137.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins